These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 26492824)

  • 1. Potent and Selective Inhibitors of Trypanosoma cruzi Triosephosphate Isomerase with Concomitant Inhibition of Cruzipain: Inhibition of Parasite Growth through Multitarget Activity.
    Aguilera E; Varela J; Birriel E; Serna E; Torres S; Yaluff G; de Bilbao NV; Aguirre-López B; Cabrera N; Díaz Mazariegos S; de Gómez-Puyou MT; Gómez-Puyou A; Pérez-Montfort R; Minini L; Merlino A; Cerecetto H; González M; Alvarez G
    ChemMedChem; 2016 Jun; 11(12):1328-38. PubMed ID: 26492824
    [TBL] [Abstract][Full Text] [Related]  

  • 2. New chemotypes as Trypanosoma cruzi triosephosphate isomerase inhibitors: a deeper insight into the mechanism of inhibition.
    Alvarez G; Martínez J; Aguirre-López B; Cabrera N; Pérez-Díaz L; de Gómez-Puyou MT; Gómez-Puyou A; Pérez-Montfort R; Garat B; Merlino A; González M; Cerecetto H
    J Enzyme Inhib Med Chem; 2014 Apr; 29(2):198-204. PubMed ID: 23406473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective inactivation of triosephosphate isomerase from Trypanosoma cruzi by brevifolin carboxylate derivatives isolated from Geranium bellum Rose.
    Gayosso-De-Lucio J; Torres-Valencia M; Rojo-Domínguez A; Nájera-Peña H; Aguirre-López B; Salas-Pacheco J; Avitia-Domínguez C; Téllez-Valencia A
    Bioorg Med Chem Lett; 2009 Oct; 19(20):5936-9. PubMed ID: 19733070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 1,2,4-thiadiazol-5(4H)-ones: a new class of selective inhibitors of Trypanosoma cruzi triosephosphate isomerase. Study of the mechanism of inhibition.
    Alvarez G; Aguirre-López B; Cabrera N; Marins EB; Tinoco L; Batthyány CI; de Gómez-Puyou MT; Puyou AG; Pérez-Montfort R; Cerecetto H; González M
    J Enzyme Inhib Med Chem; 2013 Oct; 28(5):981-9. PubMed ID: 22803666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of bis-thiazoles as inhibitors of triosephosphate isomerase from Trypanosoma cruzi. Identification of new non-mutagenic agents that are active in vivo.
    Álvarez G; Martínez J; Varela J; Birriel E; Cruces E; Gabay M; Leal SM; Escobar P; Aguirre-López B; Cabrera N; Tuena de Gómez-Puyou M; Gómez Puyou A; Pérez-Montfort R; Yaluff G; Torres S; Serna E; Vera de Bilbao N; González M; Cerecetto H
    Eur J Med Chem; 2015 Jul; 100():246-56. PubMed ID: 26094151
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pyrazol(in)e derivatives of curcumin analogs as a new class of anti-
    Matiadis D; Saporiti T; Aguilera E; Robert X; Guillon C; Cabrera N; Pérez-Montfort R; Sagnou M; Alvarez G
    Future Med Chem; 2021 Apr; 13(8):701-714. PubMed ID: 33648346
    [No Abstract]   [Full Text] [Related]  

  • 7. Recent Advances in the Development of Triose Phosphate Isomerase Inhibitors as Antiprotozoal Agents.
    Vázquez-Jiménez LK; Moreno-Herrera A; Juárez-Saldivar A; González-González A; Ortiz-Pérez E; Paz-González AD; Palos I; Ramírez-Moreno E; Rivera G
    Curr Med Chem; 2022; 29(14):2504-2529. PubMed ID: 34517794
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular docking and molecular dynamics simulation studies of Trypanosoma cruzi triosephosphate isomerase inhibitors. Insights into the inhibition mechanism and selectivity.
    Minini L; Álvarez G; González M; Cerecetto H; Merlino A
    J Mol Graph Model; 2015 May; 58():40-9. PubMed ID: 25829097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel scaffolds for inhibition of Cruzipain identified from high-throughput screening of anti-kinetoplastid chemical boxes.
    Salas-Sarduy E; Landaburu LU; Karpiak J; Madauss KP; Cazzulo JJ; Agüero F; Alvarez VE
    Sci Rep; 2017 Sep; 7(1):12073. PubMed ID: 28935948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design, synthesis, molecular modelling, and in vitro evaluation of tricyclic coumarins against Trypanosoma cruzi.
    Coelho GS; Andrade JS; Xavier VF; Sales Junior PA; Rodrigues de Araujo BC; Fonseca KDS; Caetano MS; Murta SMF; Vieira PM; Carneiro CM; Taylor JG
    Chem Biol Drug Des; 2019 Mar; 93(3):337-350. PubMed ID: 30362274
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The major cysteine proteinase of Trypanosoma cruzi: a valid target for chemotherapy of Chagas disease.
    Jose Cazzulo J; Stoka V; Turk V
    Curr Pharm Des; 2001 Aug; 7(12):1143-56. PubMed ID: 11472258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro and in vivo studies of the trypanocidal properties of WRR-483 against Trypanosoma cruzi.
    Chen YT; Brinen LS; Kerr ID; Hansell E; Doyle PS; McKerrow JH; Roush WR
    PLoS Negl Trop Dis; 2010 Sep; 4(9):. PubMed ID: 20856868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibitors of Trypanosoma cruzi Sir2 related protein 1 as potential drugs against Chagas disease.
    Gaspar L; Coron RP; KongThoo Lin P; Costa DM; Perez-Cabezas B; Tavares J; Roura-Ferrer M; Ramos I; Ronin C; Major LL; Ciesielski F; Pemberton IK; MacDougall J; Ciapetti P; Smith TK; Cordeiro-da-Silva A
    PLoS Negl Trop Dis; 2018 Jan; 12(1):e0006180. PubMed ID: 29357372
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Massive screening yields novel and selective Trypanosoma cruzi triosephosphate isomerase dimer-interface-irreversible inhibitors with anti-trypanosomal activity.
    Alvarez G; Aguirre-López B; Varela J; Cabrera M; Merlino A; López GV; Lavaggi ML; Porcal W; Di Maio R; González M; Cerecetto H; Cabrera N; Pérez-Montfort R; de Gómez-Puyou MT; Gómez-Puyou A
    Eur J Med Chem; 2010 Dec; 45(12):5767-72. PubMed ID: 20889239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tetrafluorophenoxymethyl ketone cruzain inhibitors with improved pharmacokinetic properties as therapeutic leads for Chagas' disease.
    Neitz RJ; Bryant C; Chen S; Gut J; Hugo Caselli E; Ponce S; Chowdhury S; Xu H; Arkin MR; Ellman JA; Renslo AR
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4834-4837. PubMed ID: 26144347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Giardial triosephosphate isomerase as possible target of the cytotoxic effect of omeprazole in Giardia lamblia.
    Reyes-Vivas H; de la Mora-de la Mora I; Castillo-Villanueva A; Yépez-Mulia L; Hernández-Alcántara G; Figueroa-Salazar R; García-Torres I; Gómez-Manzo S; Méndez ST; Vanoye-Carlo A; Marcial-Quino J; Torres-Arroyo A; Oria-Hernández J; Gutiérrez-Castrellón P; Enríquez-Flores S; López-Velázquez G
    Antimicrob Agents Chemother; 2014 Dec; 58(12):7072-82. PubMed ID: 25223993
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-based approach to the identification of a novel group of selective glucosamine analogue inhibitors of Trypanosoma cruzi glucokinase.
    D'Antonio EL; Deinema MS; Kearns SP; Frey TA; Tanghe S; Perry K; Roy TA; Gracz HS; Rodriguez A; D'Antonio J
    Mol Biochem Parasitol; 2015 Dec; 204(2):64-76. PubMed ID: 26778112
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Looking for combination of benznidazole and Trypanosoma cruzi-triosephosphate isomerase inhibitors for Chagas disease treatment.
    Aguilera E; Varela J; Serna E; Torres S; Yaluff G; Bilbao NV; Cerecetto H; Alvarez G; González M
    Mem Inst Oswaldo Cruz; 2018 Mar; 113(3):153-160. PubMed ID: 29412353
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Assessment of the Activity of Nitroisoxazole Derivatives against
    Moncada-Basualto M; Saavedra-Olavarría J; Rivero-Jerez PS; Rojas C; Maya JD; Liempi A; Zúñiga-Bustos M; Olea-Azar C; Lapier M; Pérez EG; Pozo-Martínez J
    Molecules; 2024 Jun; 29(12):. PubMed ID: 38930828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of levothyroxine antichagasic activity through computer-aided drug repurposing.
    Bellera CL; Balcazar DE; Alberca L; Labriola CA; Talevi A; Carrillo C
    ScientificWorldJournal; 2014; 2014():279618. PubMed ID: 24592161
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.